Fredun Pharmaceuticals Limited (FREDUN.BO)
INR 677.25
(3.59%)
INR 677.25
(3.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.86 Billion INR | 15.68% |
| 2022 | 1.6 Billion INR | 35.3% |
| 2021 | 1.18 Billion INR | 0.32% |
| 2020 | 1.18 Billion INR | 18.48% |
| 2019 | 1 Billion INR | 51.78% |
| 2018 | 659.2 Million INR | 15.44% |
| 2017 | 571.02 Million INR | 16.92% |
| 2016 | 488.37 Million INR | 24.46% |
| 2015 | 392.4 Million INR | 97.1% |
| 2014 | 199.09 Million INR | 34.51% |
| 2013 | 148.01 Million INR | 22.27% |
| 2012 | 121.05 Million INR | 19.04% |
| 2011 | 101.69 Million INR | 44.52% |
| 2010 | 70.36 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -1.21 Billion INR | -165.26% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | 1.86 Billion INR | 11.36% |
| 2023 FY | 1.86 Billion INR | 15.68% |
| 2023 Q2 | 1.67 Billion INR | 0.0% |
| 2023 Q4 | 1.86 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 1.6 Billion INR | 35.3% |
| 2022 Q4 | 1.6 Billion INR | 0.0% |
| 2022 Q2 | 1.58 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.18 Billion INR | 0.32% |
| 2021 Q2 | 1.51 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.18 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 1.18 Billion INR | 18.48% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 1.01 Billion INR | 0.0% |
| 2020 Q4 | 1.18 Billion INR | 0.0% |
| 2019 Q2 | 859.53 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 1 Billion INR | 51.78% |
| 2019 Q4 | 1 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 FY | 659.2 Million INR | 15.44% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 570.01 Million INR | 0.0% |
| 2018 Q4 | 659.2 Million INR | 0.0% |
| 2017 Q4 | 571.41 Million INR | 0.0% |
| 2017 FY | 571.02 Million INR | 16.92% |
| 2017 Q2 | 478.97 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 425.35 Million INR | 0.0% |
| 2016 FY | 488.37 Million INR | 24.46% |
| 2016 Q4 | 488.37 Million INR | 0.0% |
| 2015 Q4 | 392.4 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q2 | 261.87 Million INR | 0.0% |
| 2015 FY | 392.4 Million INR | 97.1% |
| 2015 Q3 | - INR | -100.0% |
| 2014 FY | 199.09 Million INR | 34.51% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 168.96 Million INR | 0.0% |
| 2014 Q4 | 199.09 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 148.01 Million INR | 0.0% |
| 2013 Q2 | 132.12 Million INR | 0.0% |
| 2013 FY | 148.01 Million INR | 22.27% |
| 2012 FY | 121.05 Million INR | 19.04% |
| 2012 Q4 | 121.05 Million INR | 0.0% |
| 2011 FY | 101.69 Million INR | 44.52% |
| 2010 FY | 70.36 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 117.72 Million INR | -1481.04% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -843.026% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -20879.249% |
| MedPlus Health Services Limited | 14.27 Billion INR | 86.961% |
| ANG Lifesciences India Limited | 1.66 Billion INR | -12.017% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -1069.116% |
| Bacil Pharma Limited | 1.12 Million INR | -164760.85% |
| BDH Industries Limited | 312.53 Million INR | -495.543% |
| Beryl Drugs Limited | 85.63 Million INR | -2073.477% |
| Cian Healthcare Limited | 1.03 Billion INR | -79.947% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -87366.118% |
| Concord Drugs Limited | 249.88 Million INR | -644.851% |
| Deccan Health Care Limited | 111.33 Million INR | -1571.767% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -1051.254% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -7142.03% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -823.29% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -86.809% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | -8.45% |
| Makers Laboratories Limited | 569.18 Million INR | -227.011% |
| Medi-Caps Limited | 63.01 Million INR | -2853.661% |
| Panchsheel Organics Limited | 340.2 Million INR | -447.11% |
| Parmax Pharma Limited | 117.56 Million INR | -1483.155% |
| Parnax Lab Limited | 1.17 Billion INR | -58.987% |
| Patidar Buildcon Limited | 25.57 Million INR | -7178.582% |
| Phaarmasia Limited | 211.49 Million INR | -780.058% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -538.57% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -1100.322% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -622401.338% |
| Smruthi Organics Limited | 485.72 Million INR | -283.2% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -4334.573% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | -8.581% |
| Trident Lifeline Limited | 331.26 Million INR | -461.875% |
| Transchem Limited | 6.72 Million INR | -27597.604% |
| Trinity League India Limited | 876 Thousand INR | -212374.772% |
| Tyche Industries Limited | 101.64 Million INR | -1731.229% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -962.574% |
| Vivanza Biosciences Limited | 148.63 Million INR | -1152.282% |
| PRAVEG LIMITED | 767.53 Million INR | -142.501% |
| Sastasundar Ventures Limited | 1.5 Billion INR | -24.037% |
| Sunil Healthcare Limited | 902.83 Million INR | -106.16% |
| Syschem (India) Limited | 1.07 Billion INR | -73.835% |
| Zenith Healthcare Limited | 24.03 Million INR | -7644.036% |
| Zenlabs Ethica Limited | 301.35 Million INR | -517.639% |
| Mercury Laboratories Limited | 171.18 Million INR | -987.266% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -8767.456% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -3369.493% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -85.325% |
| Roopa Industries Limited | 493.08 Million INR | -277.475% |
| PANJON LTD. | 25.38 Million INR | -7232.778% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -792.952% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -12325.923% |
| Anuh Pharma Limited | 1.54 Billion INR | -20.501% |
| Crestchem Limited | 23.94 Million INR | -7672.493% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -13784.961% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -1474.38% |
| Trimurthi Limited | 101.36 Thousand INR | -1836205.249% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -821.544% |
| Norris Medicines Limited | 278.17 Million INR | -569.108% |
| Veerhealth Care Limited | 62.78 Million INR | -2864.764% |
| Lactose (India) Limited | 536.39 Million INR | -246.997% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -123.404% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | -64.584% |
| Gennex Laboratories Limited | 535.21 Million INR | -247.765% |
| Denis Chem Lab Limited | 289.82 Million INR | -542.215% |
| Colinz Laboratories Limited | 24.1 Million INR | -7621.547% |
| Godavari Drugs Limited | 957.86 Million INR | -94.316% |
| Zenotech Laboratories Limited | 156.64 Million INR | -1088.192% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -281.122% |
| Bharat Parenterals Limited | 2.65 Billion INR | 29.935% |
| Coral Laboratories Limited | 281.83 Million INR | -560.405% |
| Evoq Remedies Limited | 116.23 Million INR | -1501.348% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -75.983% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 8.897% |
| Natural Capsules Limited | 1.47 Billion INR | -26.0% |
| Auro Laboratories Limited | 433.09 Million INR | -329.76% |